{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T23:15:50Z","timestamp":1780614950188,"version":"3.54.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T00:00:00Z","timestamp":1745539200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T00:00:00Z","timestamp":1745539200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"DOI":"10.1007\/s00345-025-05648-8","type":"journal-article","created":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T01:30:56Z","timestamp":1745544656000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Acidic urine as a prognostic factor after intravesical Bacillus Calmette\u2013Gu\u00e9rin induction therapy for nonmuscle-invasive bladder cancer"],"prefix":"10.1007","volume":"43","author":[{"given":"Hoyoung","family":"Ryu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sangchul","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Hun","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hakmin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong Jin","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Kyu","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seok-Soo","family":"Byun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byeongdo","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,25]]},"reference":[{"key":"5648_CR1","first-page":"12","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A (2024) Cancer statistics, 2024. CA Cancer J Clin 74:12\u201349","journal-title":"CA Cancer J Clin"},{"key":"5648_CR2","doi-asserted-by":"crossref","unstructured":"Kamat AM, Hahn NM, Efstathiou JA, Lerner SP, Malmstr\u00f6m PU, Choi W et al (2016) Bladder cancer. Lancet 388: 2796\u20132810","DOI":"10.1016\/S0140-6736(16)30512-8"},{"key":"5648_CR3","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.eururo.2020.12.033","volume":"79","author":"RJ Sylvester","year":"2021","unstructured":"Sylvester RJ, Rodr\u00edguez O, Hern\u00e1ndez V, Turturica D, Bauerov\u00e1 L, Bruins HM et al (2021) European association of urology (EAU) prognostic factor risk groups for non-muscle-invasive bladder cancer (nmibc) incorporating the WHO 2004\/2016 and WHO 1973 classification systems for grade: an update from the EAU NMIBC guidelines panel. Eur Urol 79:480\u2013488","journal-title":"Eur Urol"},{"key":"5648_CR4","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.eururo.2016.05.041","volume":"71","author":"M Babjuk","year":"2017","unstructured":"Babjuk M, B\u00f6hle A, Burger M, Capoun O, Cohen D, Comp\u00e9rat EM et al (2017) EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2016. Eur Urol 71:447\u2013461","journal-title":"Eur Urol"},{"key":"5648_CR5","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.euf.2021.03.016","volume":"8","author":"E Laukhtina","year":"2022","unstructured":"Laukhtina E, Abufaraj M, Al-Ani A, Ali MR, Mori K, Moschini M et al (2022) Intravesical therapy in patients with intermediate-risk non-muscle-invasive bladder cancer: a systematic review and network meta-analysis of disease recurrence. Eur Urol Focus 8:447\u2013456","journal-title":"Eur Urol Focus"},{"key":"5648_CR6","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/S0022-5347(17)58737-6","volume":"116","author":"A Morales","year":"1976","unstructured":"Morales A, Eidinger D, Bruce AW (1976) Intracavitary Bacillus Calmette-Guerin in the treatment of superficial bladder tumors. J Urol 116:180\u2013183","journal-title":"J Urol"},{"key":"5648_CR7","doi-asserted-by":"publisher","first-page":"110393","DOI":"10.1016\/j.biopha.2020.110393","volume":"129","author":"J Han","year":"2020","unstructured":"Han J, Gu X, Li Y, Wu Q (2020) Mechanisms of BCG in the treatment of bladder cancer-current Understanding and the prospect. Biomed Pharmacother 129:110393","journal-title":"Biomed Pharmacother"},{"key":"5648_CR8","doi-asserted-by":"publisher","first-page":"S199","DOI":"10.5489\/cuaj.1196","volume":"3","author":"AR Zlotta","year":"2009","unstructured":"Zlotta AR, Fleshner NE, Jewett MA (2009) The management of BCG failure in non-muscle-invasive bladder cancer: an update. Can Urol Assoc J 3:S199\u2013205","journal-title":"Can Urol Assoc J"},{"key":"5648_CR9","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/bjc.1991.326","volume":"64","author":"JR Griffiths","year":"1991","unstructured":"Griffiths JR (1991) Are cancer cells acidic? Br J Cancer 64:425\u2013427","journal-title":"Br J Cancer"},{"key":"5648_CR10","doi-asserted-by":"publisher","first-page":"979154","DOI":"10.3389\/fonc.2022.979154","volume":"12","author":"A Bogdanov","year":"2022","unstructured":"Bogdanov A, Bogdanov A, Chubenko V, Volkov N, Moiseenko F, Moiseyenko V (2022) Tumor acidity: from the hallmark of cancer to target of treatment. Front Oncol 12:979154","journal-title":"Front Oncol"},{"key":"5648_CR11","first-page":"1117","volume":"16","author":"ME Wright","year":"2005","unstructured":"Wright ME, Michaud DS, Pietinen P, Taylor PR, Virtamo J, Albanes D (2005) Estimated urine pH and bladder cancer risk in a cohort of male smokers (Finland). Cancer Causes Control 16:1117\u20131123","journal-title":"Cancer Causes Control"},{"key":"5648_CR12","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1158\/1055-9965.EPI-22-0801","volume":"32","author":"AH Fischer","year":"2023","unstructured":"Fischer AH, Wong JYY, Baris D, Koutros S, Karagas MR, Schwenn M et al (2023) Urine pH and risk of bladder cancer in Northern new England. Cancer Epidemiol Biomarkers Prev 32:1323\u20131327","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"5648_CR13","doi-asserted-by":"publisher","first-page":"20675","DOI":"10.1038\/s41598-021-00184-y","volume":"11","author":"H Ide","year":"2021","unstructured":"Ide H, Kikuchi E, Ogihara K, Niwa N, Shigeta K, Masuda T et al (2021) Urinary pH is an independent predictor of upper tract recurrence in non-muscle-invasive bladder cancer patients with a smoking history. Sci Rep 11:20675","journal-title":"Sci Rep"},{"key":"5648_CR14","doi-asserted-by":"publisher","first-page":"964571","DOI":"10.3389\/fonc.2022.964571","volume":"12","author":"JH Han","year":"2022","unstructured":"Han JH, Jeong SH, Yuk HD, Jeong CW, Kwak C, Ku JH (2022) Acidic urine is associated with poor prognosis in patients with bladder cancer undergoing radical cystectomy. Front Oncol 12:964571","journal-title":"Front Oncol"},{"key":"5648_CR15","doi-asserted-by":"publisher","first-page":"817781","DOI":"10.3389\/fonc.2021.817781","volume":"11","author":"JH Han","year":"2022","unstructured":"Han JH, Jeong SH, Yuk HD, Jeong CW, Kwak C, Ku JH (2022) Acidic urine is associated with poor prognosis of upper tract urothelial carcinoma. Front Oncol 11:817781","journal-title":"Front Oncol"},{"key":"5648_CR16","doi-asserted-by":"publisher","first-page":"1218297","DOI":"10.1155\/2018\/1218297","volume":"2018","author":"F Erra D\u00edaz","year":"2018","unstructured":"Erra D\u00edaz F, Dantas E, Geffner J (2018) Unraveling the interplay between extracellular acidosis and immune cells. Mediators Inflamm 2018:1218297","journal-title":"Mediators Inflamm"},{"key":"5648_CR17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.36456\/embrio.v16i1.7984","volume":"16","author":"R Vuillefroy de Silly","year":"2024","unstructured":"Vuillefroy de Silly R, Pericou L, Seijo B, Crespo I, Irving M (2024) Acidity suppresses CD8\u2009+\u2009T-cell function by perturbing IL-2, mTORC1, and c-Myc signaling. EMBO J 16:1\u201332","journal-title":"EMBO J"},{"key":"5648_CR18","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.eururo.2021.12.005","volume":"82","author":"M Roumigui\u00e9","year":"2022","unstructured":"Roumigui\u00e9 M, Kamat AM, Bivalacqua TJ, Lerner SP, Kassouf W, B\u00f6hle A et al (2022) International bladder cancer group consensus statement on clinical trial design for patients with bacillus Calmette-Gu\u00e9rin-exposed high-risk non-muscle-invasive bladder cancer. Eur Urol 82:34\u201346","journal-title":"Eur Urol"},{"key":"5648_CR19","doi-asserted-by":"publisher","first-page":"883","DOI":"10.2215\/CJN.00670207","volume":"2","author":"NM Maalouf","year":"2007","unstructured":"Maalouf NM, Cameron MA, Moe OW, Adams-Huet B, Sakhaee K (2007) Low urine pH: a novel feature of the metabolic syndrome. Clin J Am Soc Nephrol 2:883\u2013888","journal-title":"Clin J Am Soc Nephrol"},{"key":"5648_CR20","first-page":"599","volume":"19","author":"YH Cho","year":"2014","unstructured":"Cho YH, Lee SY, Jeong DW, Choi EJ, Nam KJ, Kim YJ et al (2014) The association between a low urine pH and the components of metabolic syndrome in the Korean population: findings based on the 2010 Korea National health and nutrition examination survey. J Res Med Sci 19:599\u2013604","journal-title":"J Res Med Sci"},{"key":"5648_CR21","doi-asserted-by":"publisher","first-page":"613366","DOI":"10.3389\/fonc.2020.613366","volume":"10","author":"Y Lu","year":"2021","unstructured":"Lu Y, Zhang W, Fan S, Liang Z, Li Z, Tian J et al (2021) Metabolic syndrome and risk of upper tract urothelial carcinoma: a case\u2013control study using surveillance, epidemiology and end results-medicare-linked database. Front Oncol 10:613366","journal-title":"Front Oncol"},{"key":"5648_CR22","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1159\/000330487","volume":"35","author":"N Nakanishi","year":"2012","unstructured":"Nakanishi N, Fukui M, Tanaka M, Toda H, Imai S, Yamazaki M et al (2012) Low urine pH is a predictor of chronic kidney disease. Kidney Blood Press Res 35:77\u201381","journal-title":"Kidney Blood Press Res"},{"key":"5648_CR23","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1007\/s11255-016-1264-5","volume":"48","author":"CE Li","year":"2016","unstructured":"Li CE, Chien CS, Chuang YC, Chang YI, Tang HP, Kang CH (2016) Chronic kidney disease as an important risk factor for tumor recurrence, progression, and overall survival in primary non-muscle-invasive bladder cancer. Int Urol Nephrol 48:993\u2013999","journal-title":"Int Urol Nephrol"},{"key":"5648_CR24","doi-asserted-by":"publisher","first-page":"684e1","DOI":"10.1016\/j.urolonc.2020.02.001","volume":"38","author":"N Fujita","year":"2020","unstructured":"Fujita N, Hatakeyama S, Momota M, Tobisawa Y, Yoneyama T, Yamamoto H et al (2020) Preoperative chronic kidney disease predicts poor prognosis in patients with primary non-muscle-invasive bladder cancer who underwent transurethral resection of the bladder tumor. Urol Oncol 38:684e1\u2013684e8","journal-title":"Urol Oncol"},{"key":"5648_CR25","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1111\/j.1442-2042.2010.02678.x","volume":"18","author":"RJ Sylvester","year":"2011","unstructured":"Sylvester RJ (2011) Bacillus Calmette-Gu\u00e9rin treatment of nonmuscle invasive bladder cancer. Int J Urol 18:113\u2013120","journal-title":"Int J Urol"},{"key":"5648_CR26","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3389\/fonc.2016.00043","volume":"6","author":"ON Gofrit","year":"2016","unstructured":"Gofrit ON, Yutkin V, Shapiro A, Pizov G, Zorn KC, Hidas G et al (2016) The response of variant histology bladder cancer to intravesical immunotherapy compared to conventional cancer. Front Oncol 6:43","journal-title":"Front Oncol"},{"key":"5648_CR27","doi-asserted-by":"publisher","first-page":"490e13","DOI":"10.1016\/j.urolonc.2022.05.016","volume":"40","author":"M Ferro","year":"2022","unstructured":"Ferro M, Barone B, Crocetto F, Lucarelli G, Busetto GM, Del Giudice F et al (2022) Predictive clinico-pathological factors to identify BCG, unresponsive patients, after re-resection for T1 high grade non-muscle invasive bladder cancer. Urol Oncol 40:490e13\u2013e490","journal-title":"Urol Oncol"},{"key":"5648_CR28","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12894-016-0122-1","volume":"16","author":"K Fukumoto","year":"2016","unstructured":"Fukumoto K, Kikuchi E, Mikami S, Miyajima A, Oya M (2016) Lymphovascular invasion status at transurethral resection of bladder tumors May predict subsequent poor response of T1 tumors to bacillus Calmette-Gu\u00e9rin. BMC Urol 16:5","journal-title":"BMC Urol"},{"key":"5648_CR29","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/j.eururo.2017.10.003","volume":"73","author":"AM Kamat","year":"2018","unstructured":"Kamat AM, Li R, O\u2019Donnell MA, Black PC, Roupret M, Catto JW et al (2018) Predicting the response to intravesical bacillus calmette-gu\u00e9rin immunotherapy: are we there yet? A systematic review. Eur Urol 73:738\u2013748","journal-title":"Eur Urol"},{"key":"5648_CR30","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1093\/carcin\/bgr048","volume":"32","author":"J Alguacil","year":"2011","unstructured":"Alguacil J, Kogevinas M, Silverman DT, Malats N, Real FX, Garc\u00eda-Closas M et al (2011) Urinary pH, cigarette smoking and bladder cancer risk. Carcinogenesis 32:843\u2013847","journal-title":"Carcinogenesis"},{"key":"5648_CR31","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1016\/S0022-5347(05)64273-5","volume":"168","author":"RJ Sylvester","year":"2002","unstructured":"Sylvester RJ, van der MEIJDEN AP, Lamm DL (2002) Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of randomized clinical trials. J Urol 168:1964\u20131970","journal-title":"J Urol"},{"key":"5648_CR32","doi-asserted-by":"publisher","first-page":"3812","DOI":"10.1182\/blood-2006-07-035972","volume":"109","author":"K Fischer","year":"2007","unstructured":"Fischer K, Hoffmann P, Voelkl S, Meidenbauer N, Ammer J, Edinger M et al (2007) Inhibitory effect of tumor cell-derived lactic acid on human T cells. Blood 109:3812\u20133819","journal-title":"Blood"},{"key":"5648_CR33","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1002\/ijc.26410","volume":"131","author":"AN Mendler","year":"2012","unstructured":"Mendler AN, Hu B, Prinz PU, Kreutz M, Gottfried E, Noessner E (2012) Tumor lactic acidosis suppresses CTL function by inhibiting p38 and JNK\/c-Jun activation. Int J Cancer 131:633\u2013640","journal-title":"Int J Cancer"},{"key":"5648_CR34","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1016\/S0022-5347(17)35678-1","volume":"150","author":"TL Ratliff","year":"1993","unstructured":"Ratliff TL, Ritchey JK, Yuan JJ, Andriole GL, Catalona WJ (1993) T-cell subsets required for intravesical BCG immunotherapy for bladder cancer. J Urol 150:1018\u20131023","journal-title":"J Urol"},{"key":"5648_CR35","doi-asserted-by":"publisher","first-page":"137ra72","DOI":"10.1126\/scitranslmed.3003586","volume":"4","author":"C Biot","year":"2012","unstructured":"Biot C, Rentsch CA, Gsponer JR, Birkh\u00e4user FD, Jusforgues-Saklani H, Lema\u00eetre F et al (2012) Preexisting BCG-specific T cells improve intravesical immunotherapy for bladder cancer. Sci Transl Med 4:137ra72","journal-title":"Sci Transl Med"},{"key":"5648_CR36","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1016\/S0022-5347(17)37668-1","volume":"147","author":"S Prescott","year":"1992","unstructured":"Prescott S, James K, Hargreave TB, Chisholm GD, Smyth JF (1992) Intravesical Evans strain BCG therapy: quantitative immunohistochemical analysis of the immune response within the bladder wall. J Urol 147:1636\u20131642","journal-title":"J Urol"},{"key":"5648_CR37","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1158\/2326-6066.CIR-16-0267","volume":"5","author":"M Kates","year":"2017","unstructured":"Kates M, Nirschl T, Sopko NA, Matsui H, Kochel CM, Reis LO et al (2017) Intravesical BCG induces CD4\u2009+\u2009T-Cell expansion in an immune competent model of bladder cancer. Cancer Immunol Res 5:594\u2013603","journal-title":"Cancer Immunol Res"},{"key":"5648_CR38","doi-asserted-by":"publisher","first-page":"615091","DOI":"10.3389\/fimmu.2020.615091","volume":"11","author":"CJ Lim","year":"2021","unstructured":"Lim CJ, Nguyen PHD, Wasser M, Kumar P, Lee YH, Nasir NJM et al (2021) Immunological hallmarks for the clinical response to BCG in bladder cancer. Front Immunol 11:615091","journal-title":"Front Immunol"},{"key":"5648_CR39","doi-asserted-by":"publisher","first-page":"7701","DOI":"10.3390\/jcm13247701","volume":"13","author":"A Myszka","year":"2024","unstructured":"Myszka A, Ciesla M, Siekierzynska A, Sendera A, Constantinou C, Karpinski P et al (2024) Predictive molecular biomarkers of bladder cancer identified by next-generation sequencing-preliminary data. J Clin Med 13:7701","journal-title":"J Clin Med"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-025-05648-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00345-025-05648-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-025-05648-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T13:50:53Z","timestamp":1767966653000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00345-025-05648-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,25]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5648"],"URL":"https:\/\/doi.org\/10.1007\/s00345-025-05648-8","relation":{},"ISSN":["1433-8726"],"issn-type":[{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,25]]},"assertion":[{"value":"12 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Institutional Review Board (IRB) of Seoul National University Bundang Hospital approved this study (IRB No. B-2410-933-106). Our research does not include animals as subjects. All procedures performed in studies involving human participants were according to the ethical standards of the institutional and\/or national research committee and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"247"}}